Note 14 - Segment Reporting and Geographic Information - Segment Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Clinical and pre-clinical expenses | $ 569 | $ 188 | $ 1,101 | $ 302 | ||
| Patent expenses | 30 | 271 | 220 | 436 | ||
| Personnel costs | 645 | 679 | 1,311 | 1,768 | ||
| Professional services | 245 | 470 | 832 | 1,442 | ||
| Other operational expenses | 242 | 341 | 499 | 610 | ||
| Other segment items | 19 | (71) | 138 | (97) | ||
| Segment net loss | 1,750 | 1,878 | 4,101 | 4,462 | ||
| Net loss (income) from discontinued operations | 3,950 | 2,771 | 8,273 | (983) | ||
| Consolidated net loss | $ 5,700 | $ 6,674 | $ 4,649 | $ (1,170) | $ 12,374 | $ 3,479 |
| X | ||||||||||
- Definition The amount of clinical and pre-clinical expenses. No definition available.
|
| X | ||||||||||
- Definition The amount of patent expenses. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|